Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.
BMC Cancer. 2018 May 24;18(1):590. doi: 10.1186/s12885-018-4497-0.
BMC Cancer. 2018.
PMID: 29793447
Free PMC article.
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
Wang T, Zhou Q, Zeng H, Zhang H, Liu Z, Shao J, Wang Z, Xiong Y, Wang J, Bai Q, Xia Y, Wang Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Chang Y, Wang X, Xu J.
Wang T, et al.
Cancer Immunol Immunother. 2020 Sep;69(9):1855-1867. doi: 10.1007/s00262-020-02583-y. Epub 2020 May 4.
Cancer Immunol Immunother. 2020.
PMID: 32367308
Free PMC article.
Item in Clipboard
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Qi Y, Chang Y, Wang Z, Chen L, Kong Y, Zhang P, Liu Z, Zhou Q, Chen Y, Wang J, Bai Q, Xia Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Wang Y, Xu J, Zhang W.
Qi Y, et al.
Cancer Immunol Immunother. 2019 Dec;68(12):2067-2080. doi: 10.1007/s00262-019-02429-2. Epub 2019 Nov 12.
Cancer Immunol Immunother. 2019.
PMID: 31720813
Free PMC article.
Item in Clipboard
Cite
Cite